Trials / Unknown
UnknownNCT04787432
Salutogenic Frailty Prevention Program for Women Aged 55 Years and Over
The Effect of Salutogenic Model Based Frailty Prevention Program on Development of Frailty and Sense of Coherence in Women Aged 55 Years and Over
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 84 (estimated)
- Sponsor
- Istanbul University - Cerrahpasa · Academic / Other
- Sex
- Female
- Age
- 55 Years
- Healthy volunteers
- Accepted
Summary
Frailty is a condition of reduced the capacity in multiple body systems and causing adverse outcomes because of decreasing the ability to cope with stressors. Female sex, the changes of the body imposed by ageing, and coping strategies for stressors are causal mechanisms in the development of frailty. This project is designed with the salutogenic model that is focused on the concepts of health, stress, and coping. The aim of this project is to assess the effect of Salutogenic Frailty Prevention Program on promoting sense of coherence and preventing the development of frailty in women aged 55 years and over
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Salutogenic Frailty Prevention Program | Laughter yoga: The first component of intervention is the laughter yoga that is a combination of warm up exercise, deep breathing exercises, childlike playfulness and laughter exercises. Each session of laughter yoga will be offered twice a weekly and 40 minutes each time. Health education: The second component of intervention consisted of six health issues which are "health, frailty and generalized sources of resistance for frailty", the most common medical condition and medication use", "physical activity", "healthy diet", "falls prevention" and "cognitive and psychosocial well-being". Case management: The third component of intervention is activities that determine each participant's health needs with the Omaha System and support them for the use of appropriate resources. |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2021-09-01
- Completion
- 2022-01-01
- First posted
- 2021-03-08
- Last updated
- 2021-03-08
Source: ClinicalTrials.gov record NCT04787432. Inclusion in this directory is not an endorsement.